Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Clinical Radiology|January 1, 1980
The metabolic effects of abdominal irradiation in man with and without dietary therapy with an elemental dietK J Foster, M S Brown, K G Alberti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 30, 1992
Development and validation of a robust specific enzyme mediated assay for phenylalanine in serumR S Campbell, G M Brearley, H Varsani, et al.
Circulation|February 2, 1999
PDGFbeta receptor blockade inhibits intimal hyperplasia in the baboonC E Hart, L W Kraiss, S Vergel, et al.
Immunogenetics|June 20, 1998
The influence of exogenous peptide on beta2-microglobulin exchange in the HLA complex: analysis in real-timeC L Morgan, A K Ruprai, A Solache, et al.
Journal of the American College of Cardiology|November 13, 2001
Interaction between smoking and the glycoprotein IIIa P1(A2) polymorphism in non-ST-elevation acute coronary syndromesK Barakat, S Kennon, G A Hitman, et al.
QJM : Monthly Journal of the Association of Physicians|November 28, 2002
Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?P M Timms, N Mannan, G A Hitman, et al.
Clinical Chemistry|January 24, 1998
Kinetics and proposed mechanism of the reaction of an immunoinhibition, particle-enhanced immunoassayJ C Thompson, A R Craig, C L Davey, et al.
British Journal of Cancer|December 1, 1995
Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapyD J King, P Antoniw, R J Owens, et al.
British Medical Journal|July 10, 1976
Whole-body in-vivo neutron activation analysis in assessing treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferolR B Naik, P Gosling, C P Price, et al.
Investigational New Drugs|February 25, 2015
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumorsJohanna C Bendell, Carla Kurkjian, Jeffrey R Infante, et al.
Pageof 15